ACADIAN ASSET MANAGEMENT LLC

Position in MYGN — Myriad Genetics Inc

CIK 916542 Boston, MA

Position in MYGN

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$10,388,650

+$4,323,840 QoQ

Shares Held

2,308,589

+134.1% QoQ

Ownership

2.44%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ACADIAN ASSET MANAGEMENT LLC holds $144,650,872 across 23 Diagnostics & Research names. MYGN ranks #6 (7.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DGX	Quest Diagnostics Inc	239,432	$46,923,883
2	MTD	Mettler Toledo International Inc/	22,818	$28,778,061
3	FLGT	Fulgent Genetics, Inc.	1,233,951	$19,619,820
4	IDXX	Idexx Laboratories Inc /De	33,998	$19,103,136
5	CSTL	Castle Biosciences Inc	484,441	$11,893,026
6	MYGN	Myriad Genetics Inc This page	2,308,589	$10,388,650
7	XGN	Exagen Inc.	689,114	$2,067,342
8	GH	Guardant Health, Inc.	13,827	$1,277,199

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,388,650	2,308,589	+134.1%	Shares	Defined	2026-05-13
2025-12-31	$6,064,810	986,148	+21.7%	Shares	Defined	2026-02-10
2025-09-30	$5,860,001	810,512	-16.4%	Shares	Defined	2025-11-13
2025-06-30	$5,146,064	969,127	+35621.6%	Shares	Defined	2025-08-07
2021-09-30	$87,602	2,713	-94.3%	Shares	Defined	2021-11-12
2021-03-31	$1,455,570	47,802	-84.4%	Shares	Defined	2021-05-11
2020-12-31	$6,045,685	305,801	0.0%	Shares	Defined	2021-02-11
2020-09-30	$3,987,645	305,801	-40.5%	Shares	Defined	2020-11-09
2020-06-30	$5,829,825	514,094	-11.5%	Shares	Defined	2020-08-12
2020-03-31	$8,312,378	580,879	—	Shares	Defined	2020-05-11
No filing history on record for this holder in this stock.